Shandong Shanda Wit Science and Technology Co Ltd (000915) - Total Assets
Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) holds total assets worth CN¥4.78 Billion CNY (≈ $699.46 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shandong Shanda Wit Science and Technology Co Ltd - Total Assets Trend (1996–2024)
This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see market value of Shandong Shanda Wit Science and Technolo for the company's overall valuation and market capitalisation.
Shandong Shanda Wit Science and Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Shandong Shanda Wit Science and Technology Co Ltd's total assets of CN¥4.78 Billion consist of 71.2% current assets and 28.8% non-current assets. Review total liabilities of Shandong Shanda Wit Science and Technolo to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 43.0% |
| Accounts Receivable | CN¥320.42 Million | 6.5% |
| Inventory | CN¥70.62 Million | 1.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥165.41 Million | 3.4% |
| Goodwill | CN¥26.13 Million | 0.5% |
Asset Composition Trend (1996–2024)
This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Shandong Shanda Wit Science and Technolo for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Shanda Wit Science and Technology Co Ltd's current assets represent 71.2% of total assets in 2024, a decrease from 80.6% in 1996.
- Cash Position: Cash and equivalents constituted 43.0% of total assets in 2024, up from 3.7% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 6.5% of total assets.
Shandong Shanda Wit Science and Technology Co Ltd Competitors by Total Assets
Key competitors of Shandong Shanda Wit Science and Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Yunnan Baiyao Group Co Ltd
SHE:000538
|
China | CN¥53.34 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
|
Jiuzhitang Co Ltd
SHE:000989
|
China | CN¥5.73 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Shandong Shanda Wit Science and Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.12 | 8.38 | 3.43 |
| Quick Ratio | 6.96 | 8.07 | 3.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.90 Billion | CN¥2.74 Billion | CN¥1.62 Billion |
Shandong Shanda Wit Science and Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shandong Shanda Wit Science and Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.62 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -5.1% |
| Total Assets | CN¥4.93 Billion |
| Market Capitalization | $823.99 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Shanda Wit Science and Technology Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Shandong Shanda Wit Science and Technology Co Ltd's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Shandong Shanda Wit Science and Technology Co Ltd (1996–2024)
The table below shows the annual total assets of Shandong Shanda Wit Science and Technology Co Ltd from 1996 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.93 Billion ≈ $721.55 Million |
-5.14% |
| 2023-12-31 | CN¥5.20 Billion ≈ $760.67 Million |
+10.83% |
| 2022-12-31 | CN¥4.69 Billion ≈ $686.37 Million |
+19.19% |
| 2021-12-31 | CN¥3.94 Billion ≈ $575.88 Million |
+6.51% |
| 2020-12-31 | CN¥3.69 Billion ≈ $540.69 Million |
+17.21% |
| 2019-12-31 | CN¥3.15 Billion ≈ $461.30 Million |
+8.72% |
| 2018-12-31 | CN¥2.90 Billion ≈ $424.32 Million |
+4.49% |
| 2017-12-31 | CN¥2.78 Billion ≈ $406.07 Million |
+11.80% |
| 2016-12-31 | CN¥2.48 Billion ≈ $363.23 Million |
+19.28% |
| 2015-12-31 | CN¥2.08 Billion ≈ $304.50 Million |
+6.46% |
| 2014-12-31 | CN¥1.95 Billion ≈ $286.03 Million |
+22.80% |
| 2013-12-31 | CN¥1.59 Billion ≈ $232.92 Million |
+18.62% |
| 2012-12-31 | CN¥1.34 Billion ≈ $196.36 Million |
+15.72% |
| 2011-12-31 | CN¥1.16 Billion ≈ $169.68 Million |
+1.86% |
| 2010-12-31 | CN¥1.14 Billion ≈ $166.58 Million |
+2.58% |
| 2009-12-31 | CN¥1.11 Billion ≈ $162.38 Million |
+6.71% |
| 2008-12-31 | CN¥1.04 Billion ≈ $152.17 Million |
+4.69% |
| 2007-12-31 | CN¥993.28 Million ≈ $145.35 Million |
+6.34% |
| 2006-12-31 | CN¥934.10 Million ≈ $136.69 Million |
-1.90% |
| 2005-12-31 | CN¥952.21 Million ≈ $139.34 Million |
+26.05% |
| 2004-12-31 | CN¥755.44 Million ≈ $110.54 Million |
+5.65% |
| 2003-12-31 | CN¥715.07 Million ≈ $104.64 Million |
+27.36% |
| 2002-12-31 | CN¥561.43 Million ≈ $82.16 Million |
+15.94% |
| 2001-12-31 | CN¥484.25 Million ≈ $70.86 Million |
+21.20% |
| 2000-12-31 | CN¥399.55 Million ≈ $58.47 Million |
+7.90% |
| 1999-12-31 | CN¥370.30 Million ≈ $54.19 Million |
+54.98% |
| 1998-12-31 | CN¥238.93 Million ≈ $34.96 Million |
+7.89% |
| 1997-12-31 | CN¥221.46 Million ≈ $32.41 Million |
+13.78% |
| 1996-12-31 | CN¥194.64 Million ≈ $28.48 Million |
-- |
About Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more